...
首页> 外文期刊>The Journal of Experomental Medicine >Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.
【24h】

Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.

机译:外源肽竞争内源性抗原向主要组织相容性复合物II类限制性T细胞的呈递。

获取原文

摘要

Antigen-presenting cells (APC) transfected with a construct encoding the hen egg-white lysozyme (HEL) amino acid sequence 1-80 constitutively present HEL peptides complexed to major histocompatibility complex (MHC) class II molecules to specific T cell hybridomas, indicating that endogenous cellular antigens can be efficiently presented to class II-restricted T cells. Here we show that exogenous peptide competitors added to HEL-transfected APC can inhibit the presentation of endogenous HEL peptides to class II-restricted T cells. The inhibition is specific for the class II molecule binding the competitor peptide, and it affects to the same extent presentation of exogenous or endogenous HEL peptides. These results, demonstrating that an exogenous competitor can inhibit class II-restricted T cell activation induced by endogenous as well as exogenous antigen, suggest lack of strict compartmentalization between endogenous and exogenous pathways of antigen presentation. Since autoreactive T cells may recognize endogenous, as well as exogenous antigens, the results have implications for the treatment of autoimmune diseases by MHC blockade.
机译:转染了编码鸡卵白溶菌酶(HEL)氨基酸序列1-80的构建体的抗原呈递细胞(APC)构成了与主要组织相容性复合物(MHC)II类分子复合的HEL肽,构成了特定的T细胞杂交瘤。内源性细胞抗原可以有效地呈递给II类限制性T细胞。在这里,我们显示添加到HEL转染的APC中的外源肽竞争者可以抑制内源性HEL肽向II类限制性T细胞的呈递。该抑制对于结合竞争肽的II类分子是特异性的,并且在相同程度上影响外源或内源HEL肽的呈递。这些结果表明,外源性竞争者可以抑制由内源性抗原和外源性抗原诱导的II类限制性T细胞活化,表明抗原呈递的内源性途径与外源性途径之间缺乏严格的区室化。由于自身反应性T细胞可以识别内源性抗原和外源性抗原,因此该结果对通过MHC阻断治疗自身免疫性疾病具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号